Clinical Trial Outcome Analysis in R

Clinical Trials and outcome analysis are necessary to understand the new effective treatment methods and how they can be used for the public and medical advances. This usually involves the statistical analysis and interpretations of the outcomes. R is a powerful statistical programming language popularly known for such analysis because of its wide range of libraries and packages. This article will explore the study of clinical trial outcomes using R Programming Language.

COVID-19 Clinical Trials Analysis

The dataset consists of 5783 observations and 27 variables related to clinical trials like the status of the trial, available study results, medical conditions, gender, age, sex, type of study, etc. Using this dataset we will analyze the clinical trial outcomes and how they help us in medical and research.

Dataset Link: COVID-19 Clinical Trials Analysis

Load the dataset and libraries

We will use two libraries dplyr and ggplot for data analysis and visualization of graphs. Make sure to change the path of the data with the original one on your PC.

Output:

Rank NCT.Number
1 1 NCT04785898
2 2 NCT04595136
3 3 NCT04395482
4 4 NCT04416061
5 5 NCT04395924
6 6 NCT04516954
 Title
1 Diagnostic Performance of the ID Now™ COVID-19 Screening Test Versus Simplexa™ COV
3 Lung CT Scan Analysis of SARS-CoV2 Induced Lung Injury
4 The Role of a Private Hospital in Hong Kong Amid COVID-19 Pandemic
5 Maternal-foetal Transmission of SARS-Cov-2
6 Convalescent Plasma for COVID-19 Patients
 Acronym Status Study.Results
1 COVID-IDNow Active, not recruiting No Results Available
2 COVID-19 Not yet recruiting No Results Available
3 TAC-COVID19 Recruiting No Results Available
4 COVID-19 Active, not recruiting No Results Available
5 TMF-COVID-19 Recruiting No Results Available
6 CPCP Enrolling by invitation No Results Available
 Conditions
1 Covid19
2 SARS-CoV-2 Infection
3 covid19
4 COVID
5 Maternal Fetal Infection Transmission|COVID-19|SARS-CoV 2
6 COVID 19

5 Diagnostic Test: Diagnosis of SARS-Cov2 by RT-PCR an
6 

1 .... 
 Gender Age Phases Enrollment
1 All 18 Years and older (Adult, Older Adult) Not Applicable 1000
2 All 18 Years and older (Adult, Older Adult) Phase 1|Phase 2 60
3 All 18 Years and older (Adult, Older Adult) 500
4 All Child, Adult, Older Adult 2500
5 Female 18 Years to 48 Years (Adult) 50
6 All 18 Years to 75 Years (Adult, Older Adult) Early Phase 1 10
 Funded.Bys Study.Type
1 Other Interventional
2 Other Interventional
3 Other Observational
4 Industry Observational
5 Other Observational
6 Other Interventional .... 

Data Preprocessing

In this step, we look for the missing values in our dataset so that they do not alter our outcomes.

Output:

 Rank NCT.Number Title 
 0 0 0 
 Acronym Status Study.Results 
 0 0 0 
 Conditions Interventions Outcome.Measures 
 0 0 0 
 Sponsor.Collaborators Gender Age 
 0 0 0 
 Phases Enrollment Funded.Bys 
 0 34 0 
 Study.Type Study.Designs Other.IDs 
 0 0 0 
 Start.Date Primary.Completion.Date Completion.Date 
 0 0 0 
 First.Posted Results.First.Posted Last.Update.Posted 
 0 0 0 
 Locations Study.Documents URL 
 0 0 0 

Visualization of the Clinical Trial Outcome data

We will plot the age distribution of the all the participants.

Output:

Comparing Treatment Outcomes

Use statistical tests to compare the outcomes of different treatment groups.

Output:

Geographical Distribution of the Trials

Examining the geographical distribution can highlight the global reach and regional focus of clinical trials which is important in a disease like COVID-19 because it is spreads easily with contact.

Output:

Analysis of Gender Distribution Across the Trials

Understanding the gender distribution in clinical trials is important for assessing the inclusivity and diversity of the research.

Output:

Here, we can see women were more than men in the clinical trials so they dominate in the results obtained. This should be taken care as the anatomy is different men, women and other gender.

Analysis of Interventions Used in the Clinical Trials

Identifying the most common interventions can reveal the types of treatments being tested.

Output:

Success Rate of Clinical Trials Based on Their Status

Understanding the success rate (completion rate) of clinical trials based on their status can provide insights into the efficiency and outcomes of clinical research.

Output:

Patient Outcome Analysis

Patient outcomes are critical indicators of the effectiveness and safety of clinical interventions. Analyzing patient outcomes in clinical trials can provide insights into the efficacy of treatments, side effects, and overall patient health improvements. There are many parameters that we can use to improve the effectiveness and efficiency of the clinical trials:

• Focus on Successful Interventions: Trials with high success rates should be prioritized and taken into further research and development.
• Enhance Outcome Reporting: To improve the quality of the trials they must be reported consistently and continuously. The outcome measures should be well defined.
• Patient-Centric Outcomes: Parameters that directly pay attention to the treatment of the patient should be taken into account such as symptom relief, functional improvements, and survival rates.

Conclusion

This article discussed the clinical trial outcome analysis and how it helps in medicine and research domain. We discussed how packages in R language help us in analysis and visualization of our results for better understanding.